These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18314062)

  • 21. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation oncology: past achievements and ongoing controversies.
    Mitchell JB; Glatstein E
    Cancer Res; 1991 Sep; 51(18 Suppl):5065s-5073s. PubMed ID: 1884382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microarrays and their relevance to the urologist.
    Shergill IS; Rao AR; Anjum FH; Arya M; Patel HR; Mundy AR
    J Urol; 2006 Jan; 175(1):19-26. PubMed ID: 16406863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of site-specific prognostic morbidity-mortality studies and internal outcome focus studies in radiation oncology.
    Gossman MS
    J Am Coll Radiol; 2011 Jul; 8(7):490-6. PubMed ID: 21723486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commercialized multigene predictors of clinical outcome for breast cancer.
    Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
    Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basis of radiotherapy for improved tumor control and preservation of normal function].
    Suzuki N
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3099-104. PubMed ID: 2782910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Insights in Radiation Combination Therapies: Influence of Omics and Novel Targeted Agents in Defining New Concepts in Radiation Biology and Clinical Radiation Oncology.
    Ahmed MM; Narendra A; Prasanna P; Coleman CN; Krishnan S
    Semin Radiat Oncol; 2016 Oct; 26(4):251-3. PubMed ID: 27619246
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The principles of palliative radiotherapy: a radiobiologist's perspective.
    Withers HR
    Can J Oncol; 1996 Feb; 6 Suppl 1():12-6. PubMed ID: 8853533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.
    Rutman AM; Kuo MD
    Eur J Radiol; 2009 May; 70(2):232-41. PubMed ID: 19303233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
    Metias SM; Lianidou E; Yousef GM
    J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of radiation oncology centres in Australia: report of the Radiation Oncology Treatment Quality Program.
    Kolybaba M; Kron T; Harris J; O'Brien P; Kenny L
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):382-95. PubMed ID: 19695046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiogenomics - current status, challenges and future directions.
    Andreassen CN; Schack LM; Laursen LV; Alsner J
    Cancer Lett; 2016 Nov; 382(1):127-136. PubMed ID: 26828014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation therapy: experience in lndian patients.
    Biswas LN; Deb AR; Pal S
    J Indian Med Assoc; 2005 Sep; 103(9):486-8. PubMed ID: 16493870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of cerebral surgery: a kaleidoscope of opportunities.
    Elder JB; Hoh DJ; Oh BC; Heller AC; Liu CY; Apuzzo ML
    Neurosurgery; 2008 Jun; 62(6 Suppl 3):1555-79; discussion 1579-82. PubMed ID: 18695575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour banking: the Spanish design.
    Morente MM; de Alava E; Fernandez PL
    Pathobiology; 2007; 74(4):245-50. PubMed ID: 17709967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-change symposium: status and future of modern radiation oncology-from technology to biology.
    Corradini S; Niyazi M; Verellen D; Valentini V; Walsh S; Grosu AL; Lauber K; Giaccia A; Unger K; Debus J; Pieters BR; Guckenberger M; Senan S; Budach W; Rad R; Mayerle J; Belka C
    Radiat Oncol; 2021 Feb; 16(1):27. PubMed ID: 33541387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.